RNA-seq
Viome Life Sciences Raises $86.5M in Oversubscribed Series C Round
The funding will be used to further develop its portfolio of personalized health tests and to support an expansion into the retail space.
RealSeq Biosciences Raises $1.5M in Oversubscribed Seed Financing Round
The company will use the funding to validate its RiboMarker platform and further develop its laboratory-developed test for Valley Fever.
The company had to step back from an initial focus on cardiovascular disease but believes its new target will have an easier path to market.
The five-year, EU-funded project, called MensEndoDiag, will explore the use of menstrual blood as a sample type.
With $13 million in new funding in hand, the small bioinformatics company aims to take on Big Pharma and will look to partner with major molecular labs.